In the ever-evolving landscape of biomedical research, the need for reliable, consistent, and ready-to-use cell models has never been more critical. ATCC, a leading provider of biological materials, ...
This poster was originally authored by John Vincent, Matthew Burnham, Gerrit Daubner, and Martin Main of the Medicines Discovery Catapult. It was presented at ELRIG Drug Discovery 2023. Methods to ...
Serum amyloid A (SAA) is an acute-phase protein widely used as a biomarker for inflammation, infection, and disease monitoring. Accurate laboratory measurement of SAA is essential for clinical ...
Potency assays are essential for product quality and patient safety. These tests enable a direct measurement of a biologic's functional activity, verifying that the therapy works as intended. Potency ...
Friends of Cancer Research initiated a research partnership, inviting HRD assay developers to participate in two blinded analyses. In the first, 11 assay developers reported HRD status for the Cancer ...
A robust screening assay forms the foundation of reliable high-throughput screening (HTS), directly influencing data quality, hit identification, and downstream decision-making. In drug discovery and ...
The challenges in high-throughput screening (HTS) continue to shape how laboratories design, execute, and interpret large-scale biological assays. As screening campaigns expand in scale and complexity ...
You don't want to miss this! To permanently access this eBook for free, fill out the short form below. Developing robust, reproducible antibody pair-based immunoassays is critical for guiding drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results